Oruka Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Oruka Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2010 to Q3 2024.
  • Oruka Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 15M shares, a 4.19% increase year-over-year.
  • Oruka Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 14.4M shares, a 0.04% increase from 2022.
  • Oruka Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 14.4M shares, a 3.64% increase from 2021.
  • Oruka Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 13.9M shares.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 15M +604K +4.19% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 14.5M +96.7K +0.67% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 14.5M +91K +0.63% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 14.4M +5.73K +0.04% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-01
Q3 2023 14.4M 0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-18
Q2 2023 14.4M 0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 14.4M 0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 14.4M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-01
Q3 2022 14.4M 0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-18
Q2 2022 14.4M 0 0% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-21
Q1 2022 14.4M Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-24
Q3 2021 14.4M Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 14.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q4 2014 20.5M +11.9M +138% Oct 1, 2014 Dec 31, 2014 10-K 2015-03-19
Q3 2014 21M +10.2M +94.1% Jul 1, 2014 Sep 30, 2014 10-Q 2014-11-12
Q2 2014 21M +16.1M +325% Apr 1, 2014 Jun 30, 2014 10-Q 2014-08-13
Q1 2014 18.8M +15.7M +518% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-13
Q4 2013 8.63M +6.41M +288% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-19
Q3 2013 10.8M +8.55M +374% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 4.95M +2.92M +144% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 3.04M +1.01M +49.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 2.23M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-20
Q3 2012 2.29M -8.23M -78.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 2.03M -8.1M -80% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-13
Q1 2012 2.03M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q3 2011 10.5M Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 10.1M +1.4M +16% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-13
Q2 2010 8.73M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.